RxDoctor Payments DataLook up a doctor →

David Naylor, MD

Family Medicine · Conway, ARNPI 1730166844

Payments from drug & device makers

$17,479in general payments, 2019–2025

Across 1,306 payments — averaging $13.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • GSK$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$986
  • plus $9K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)185$2,036
Novo Nordisk127$1,836
GSK205$1,467
AstraZeneca46$1,414
Lilly USA, LLC105$1,160
Pfizer91$986
Sitesaver Inc.3$807
Otsuka America Pharmaceutical, Inc.44$783
Abbott55$688
Amgen(2 entities)44$630
Astellas Pharma US Inc30$623
Johnson & Johnson42$457
Amarin Pharma, Inc.27$399
Boehringer Ingelheim20$280
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$271
Supernus Pharmaceuticals, Inc.12$244
Esperion Therapeutics, Inc.17$241
Biohaven Pharmaceuticals, Inc.25$238
Tris Pharma Inc13$237
Biohaven Pharmaceutical Holding Company Ltd.23$227
Bayer15$213
Merck19$210
Novartis20$205
Teva Pharmaceuticals USA, Inc.13$166
Corium, LLC6$141
Jazz Pharmaceuticals Inc.7$115
Sanofi-aventis U.S. LLC9$112
Boston Scientific4$104
Takeda Pharmaceuticals U.S.A., Inc.6$104
Exact Sciences6$91
Phathom Pharmaceuticals, Inc.7$90
Sunovion Pharmaceuticals Inc.6$82
Sumitomo Pharma America, Inc.10$77
Kowa Pharmaceuticals America, Inc.5$65
Shire North American Group Inc4$53
Genentech USA, Inc.4$53
Collegium Pharmaceutical, Inc.3$50
Corcept Therapeutics3$48
Antares Pharma, Inc.3$46
Eisai Inc.3$40
Dexcom, Inc.2$37
Almatica Pharma LLC2$33
Globus Medical1$32
Alnylam Pharmaceuticals Inc.1$28
Radius Health, Inc.2$25
Avanir Pharmaceuticals, Inc.2$25
Shield Therapeutics Inc1$23
Ironshore Pharmaceuticals Inc.1$22
Insulet Corporation1$19
Mylan Specialty L.p.1$19
Lundbeck LLC1$18
Agios Pharmaceuticals, Inc.1$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Nestle Healthcare Nutrition Inc.1$15
Ironwood Pharmaceuticals, Inc1$14
Noven Therapeutics, LLC1$13
Nevro Corp.1$12
Currax Pharmaceuticals LLC1$11
E.r. Squibb & Sons, L.L.C.1$11

How this compares

$17,479 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas →

Medicare billing

Part B allowed, 2024
$31,633
Medicare patients
280
Services billed
506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Conway

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →